Consensus $3.75. Affirms 2024 product sales outlook $27.1B-$27.5B.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GILD:
- Options Volatility and Implied Earnings Moves Today, August 08, 2024
- Tango Therapeutics reports Q2 EPS (24c), consensus (34c)
- GILD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Options Volatility and Implied Earnings Moves This Week, August 05 – August 09, 2024
- Compugen’s IND for COM503 in solid tumors cleared by FDA